Edgewise Therapeutics, Inc. (EWTX) has 68 open-market insider trades by 12 insiders since 2021. Over the last six months insiders net sold $9.4M. The most active filer is Alan J. Russell, CSO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Peter A. Thompson | Dir10% Owner | — | 5 | $41.7M | 2025-04-03 |
| Alan J. Russell | CSO | — | 18 | $24.1M | 2026-08-12 |
| Novo Holdings A/S | 10% Owner | — | 2 | $20.0M | 2022-09-14 |
| OrbiMed Genesis GP LLC | Dir10% Owner | — | 2 | $15.0M | 2025-04-03 |
| R. Michael Carruthers | CFO | — | 5 | $5.8M | 2025-08-12 |
| John R. Moore | CLO | — | 14 | $4.2M | 2026-08-12 |
| Badreddin Edris | Dir | — | 1 | $3.4M | 2026-01-21 |
| Behrad Derakhshan | — | — | 7 | $3.1M | 2026-08-12 |
| Joanne M. Donovan | CMO | — | 6 | $1.8M | 2026-08-13 |
| Kevin Koch | CEOPres | — | 5 | $1.3M | 2026-08-12 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Kevin Koch | CEO & President | Sell | $785K | 2026-08-12 |
| Joanne M. Donovan | CMO | Sell | $413K | 2026-08-12 |
| John R. Moore | CLO | Sell | $220K | 2026-08-12 |
| Alan J. Russell | CSO | Sell | $258K | 2026-08-12 |
| Behrad Derakhshan | — | Sell | $223K | 2026-08-12 |
| Alan J. Russell | CSO | Sell | $7.9M | 2026-07-01 |
Companies that share insiders with EWTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Joanne M. Donovan | CMO | Sell | $2.1M | 2026-05-04 |
| Joanne M. Donovan | CMO | Sell | $926K | 2026-04-01 |
| Joanne M. Donovan | CMO | Sell | $1.4M | 2026-03-31 |
| Joanne M. Donovan | CMO | Sell | $1.0M | 2026-03-27 |
| Badreddin Edris | Director | Sell | $3.4M | 2026-01-21 |
| Alan J. Russell | CSO | Sell | $2.1M | 2025-11-12 |
| Jonathan C. Fox | Director | Buy | $199K | 2025-11-11 |
| Alan J. Russell | CSO | Sell | $1.5M | 2025-08-26 |
| Joanne M. Donovan | CMO | Sell | $38K | 2025-08-12 |